These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34061355)

  • 1. Therapeutic potential of megadose vitamin C to reverse organ dysfunction in sepsis and COVID-19.
    May CN; Bellomo R; Lankadeva YR
    Br J Pharmacol; 2021 Oct; 178(19):3864-3868. PubMed ID: 34061355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of the Pathophysiological Responses to Gram-Negative Sepsis by Megadose Vitamin C.
    Lankadeva YR; Peiris RM; Okazaki N; Birchall IE; Trask-Marino A; Dornom A; Vale TAM; Evans RG; Yanase F; Bellomo R; May CN
    Crit Care Med; 2021 Feb; 49(2):e179-e190. PubMed ID: 33239507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of cerebral ischaemia and hypoxia and of sickness behaviour by megadose sodium ascorbate in ovine Gram-negative sepsis.
    May CN; Ow CP; Pustovit RV; Lane DJ; Jufar AH; Trask-Marino A; Peiris RM; Gunn A; Booth LC; Plummer MP; Bellomo R; Lankadeva YR
    Br J Anaesth; 2024 Aug; 133(2):316-325. PubMed ID: 38960833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin C-An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19.
    Holford P; Carr AC; Jovic TH; Ali SR; Whitaker IS; Marik PE; Smith AD
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin C as a treatment for organ failure in sepsis.
    Wang Z; Liu L; Liu L
    Eur J Med Res; 2023 Jul; 28(1):222. PubMed ID: 37408078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessening Organ dysfunction with VITamin C (LOVIT): protocol for a randomized controlled trial.
    Masse MH; Ménard J; Sprague S; Battista MC; Cook DJ; Guyatt GH; Heyland DK; Kanji S; Pinto R; Day AG; Cohen D; Annane D; McGuinness S; Parke R; Carr A; Arabi Y; Vijayaraghavan BKT; D'Aragon F; Carbonneau É; Maslove D; Hunt M; Rochwerg B; Millen T; Chassé M; Lebrasseur M; Archambault P; Deblois E; Drouin C; Lellouche F; Lizotte P; Watpool I; Porteous R; Clarke F; Marinoff N; Belley-Côté É; Bolduc B; Walker S; Iazzetta J; Adhikari NKJ; Lamontagne F;
    Trials; 2020 Jan; 21(1):42. PubMed ID: 31915072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of vitamin C for adjuvant sepsis therapy.
    Wilson JX
    Antioxid Redox Signal; 2013 Dec; 19(17):2129-40. PubMed ID: 23682970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial.
    Fowler AA; Truwit JD; Hite RD; Morris PE; DeWilde C; Priday A; Fisher B; Thacker LR; Natarajan R; Brophy DF; Sculthorpe R; Nanchal R; Syed A; Sturgill J; Martin GS; Sevransky J; Kashiouris M; Hamman S; Egan KF; Hastings A; Spencer W; Tench S; Mehkri O; Bindas J; Duggal A; Graf J; Zellner S; Yanny L; McPolin C; Hollrith T; Kramer D; Ojielo C; Damm T; Cassity E; Wieliczko A; Halquist M
    JAMA; 2019 Oct; 322(13):1261-1270. PubMed ID: 31573637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin C in sepsis.
    Wilson JX; Wu F
    Subcell Biochem; 2012; 56():67-83. PubMed ID: 22116695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
    Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D
    Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus meeting on "Relevance of parenteral vitamin C in acute endothelial dependent pathophysiological conditions (EDPC)".
    Lehr HA; Germann G; McGregor GP; Migeod F; Roesen P; Tanaka H; Uhlig C; Biesalski HK
    Eur J Med Res; 2006 Dec; 11(12):516-26. PubMed ID: 17182364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micronutrients in Sepsis and COVID-19: A Narrative Review on What We Have Learned and What We Want to Know in Future Trials.
    Rossetti M; Martucci G; Starchl C; Amrein K
    Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33925791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Emerging Role of Vitamin C as a Treatment for Sepsis.
    Kashiouris MG; L'Heureux M; Cable CA; Fisher BJ; Leichtle SW; Fowler AA
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 31978969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose hydralazine improves endotoxin-induced coagulopathy and multiple organ dysfunction via its anti-inflammatory and anti-oxidative/nitrosative properties.
    Huang HC; Hsiao TS; Liao MH; Tsao CM; Shih CC; Wu CC
    Eur J Pharmacol; 2020 Sep; 882():173279. PubMed ID: 32561290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin C for the treatment of sepsis: The scientific rationale.
    Marik PE
    Pharmacol Ther; 2018 Sep; 189():63-70. PubMed ID: 29684467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis.
    Fowler AA; Syed AA; Knowlson S; Sculthorpe R; Farthing D; DeWilde C; Farthing CA; Larus TL; Martin E; Brophy DF; Gupta S; ; Fisher BJ; Natarajan R
    J Transl Med; 2014 Jan; 12():32. PubMed ID: 24484547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant therapy in critical care--is the microcirculation the primary target?
    Biesalski HK; McGregor GP
    Crit Care Med; 2007 Sep; 35(9 Suppl):S577-83. PubMed ID: 17713412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in sepsis: Pathophysiological implications justifying antioxidant co-therapy.
    Prauchner CA
    Burns; 2017 May; 43(3):471-485. PubMed ID: 28034666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed ascorbate bolus protects against maldistribution of microvascular blood flow in septic rat skeletal muscle.
    Tyml K; Li F; Wilson JX
    Crit Care Med; 2005 Aug; 33(8):1823-8. PubMed ID: 16096461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.